Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer
Authors:
- 4 February 2023
- journal article
- research article
- Published by Springer Nature in Gastric Cancer
- Vol. 26 (3) , 364-378
Abstract
Background The prognosis of advanced gastric cancer (GC) invading the gastric serosa remains poor, mainly owing to high incidence of peritoneal recurrence. Patients with peritoneal metastases are often treated with neoadjuvant intraperitoneal and systemic chemotherapies (NIPS). Good responders to NIPS often undergo conversion gastrectomy. This study aims to explore biomarkers predicting the occurrence of peritoneal metastasis (PM) and evaluating the efficacy of NIPS in GC patients. Methods We collected six peritoneal lavage (PL) samples from two patients with PM, two without PM, and two with diminished PM after NIPS via intraperitoneal access ports. We equally isolated microRNAs from exosomes derived from PL samples for deep sequencing. Two microRNAs (hsa-let-7g-3p and hsa-miR-10395-3p) were identified, and their expression levels were examined in PL samples of 99 GC patients using qRT-PCR. Moreover, we performed in vivo and in vitro functional assays to investigate effects of these microRNAs on metastasis and chemoresistance of GC cells. Results Exosomal microRNA expression profiling of six PL samples indicated that the microRNA signature in exosomes of PLs from patients with diminished PM was similar to that from patients without PM. Expression levels of hsa-let-7g-3p and hsa-miR-10395-3p were associated with PM. In vivo and in vitro functional assays confirmed that hsa-let-7g-3p and hsa-miR-10395-3p are involved in GC metastasis and chemoresistance. Conclusion PL-derived exosomes in GC contain large amounts of microRNAs related to PM. Moreover, hsa-let-7g-3p and hsa-miR-10395-3p could be used as biomarkers predicting PM and NIPS efficacy and are involved in GC metastasis and chemoresistance.Keywords
Funding Information
- Major Research Plan (81772518, 82002463, 82173219)
This publication has 35 references indexed in Scilit:
- The biology and function of exosomes in cancerJournal of Clinical Investigation, 2016
- Exploring miRNA based approaches in cancer diagnostics and therapeuticsCritical Reviews in Oncology/Hematology, 2016
- Advanced gastric cancer: Current treatment landscape and future perspectivesWorld Journal of Gastroenterology, 2016
- Global burden of gastric cancer attributable toHelicobacterpyloriInternational Journal of Cancer, 2014
- Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant AscitesAnnals of Surgical Oncology, 2013
- Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living CellsJournal of Biological Chemistry, 2010
- MicroRNAs: Novel regulators in the hallmarks of human cancerCancer Letters, 2009
- Interactome of Transforming Growth Factor-β Type I Receptor (TβRI): Inhibition of TGFβ Signaling by Epac1Journal of Proteome Research, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003